診療項目

facebook

Prolia® (Denosumab Injection)

Osteoporosis is a chronic bone disease that leads to reduced bone density, making bones fragile and increasing fracture risk, often without symptoms until a fracture occurs. Common fracture sites include the femur, spine, and forearm, with fractures sometimes resulting from minor bumps or falls.


Protect Your Bones
Recent research has identified Osteoprotegerin (OPG), a protein essential for preventing bone loss. After menopause, decreased estrogen levels can impair OPG function, increasing osteoporosis risk.


Rapidly Combat Bone Loss
Prolia mimics OPG, effectively preventing bone loss and increasing bone density more than traditional oral bisphosphonates. It does not accumulate in the body, alleviating concerns about long-term use.

 

Back